These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9746807)

  • 1. Clinical significance of Arg306 mutations of factor V gene.
    Liang R; Lee CK; Wat MS; Kwong YL; Lam CK; Liu HW
    Blood; 1998 Oct; 92(7):2599-600. PubMed ID: 9746807
    [No Abstract]   [Full Text] [Related]  

  • 2. The prevalence of factor V Arg306-->Thr (factor V Cambridge) and factor V Arg306-->Gly mutations in different human populations.
    Franco RF; Elion J; Tavella MH; Santos SE; Zago MA
    Thromb Haemost; 1999 Feb; 81(2):312-3. PubMed ID: 10064012
    [No Abstract]   [Full Text] [Related]  

  • 3. A new factor V gene polymorphism (His 1254 Arg) present in subjects of african origin mimics the R2 polymorphism (His 1299 Arg).
    Lunghi B; Castoldi E; Mingozzi F; Bernardi F
    Blood; 1998 Jan; 91(1):364-5. PubMed ID: 9414311
    [No Abstract]   [Full Text] [Related]  

  • 4. High prevalence of the FVR506Q mutation causing APC resistance in a region of southern Sweden with a high incidence of venous thrombosis.
    Zöller B; Norlund L; Leksell H; Nilsson JE; von Schenck H; Rosén U; Jepsson JO; Dahlbäck B
    Thromb Res; 1996 Sep; 83(6):475-7. PubMed ID: 8885142
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of activated protein C resistance in healthy Hong Kong Chinese blood donors--correlation with absence of Arg506-Gln mutation of factor V gene.
    Chan LC; Bourke C; Lam CK; Liu HW; Brookes S; Jenkins V; Pasi J
    Thromb Haemost; 1996 Mar; 75(3):522-3. PubMed ID: 8701422
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistance to activate protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons.
    Dahlbäck B
    Thromb Haemost; 1995 May; 73(5):739-42. PubMed ID: 7482395
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel factor V null mutation detected in a thrombophilic patient with pseudo-homozygous APC resistance and in an asymptomatic unrelated subject.
    Lunghi B; Castoldi E; Mingozzi F; Bernardi F; Castaman G
    Blood; 1998 Aug; 92(4):1463-4. PubMed ID: 9694743
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. The French Network on the behalf of INSERM.
    Gandrille S; Greengard JS; Alhenc-Gelas M; Juhan-Vague I; Abgrall JF; Jude B; Griffin JH; Aiach M
    Blood; 1995 Jul; 86(1):219-24. PubMed ID: 7795227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
    De Stefano V; Leone G
    Haematologica; 1995; 80(4):344-56. PubMed ID: 7590506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis.
    Bertina RM; Reitsma PH; Rosendaal FR; Vandenbroucke JP
    Thromb Haemost; 1995 Jul; 74(1):449-53. PubMed ID: 8578504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1995 Jul; 74(1):139-48. PubMed ID: 8578447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to activated protein C due to factor V R506Q mutation as a cause of venous thrombosis.
    Dahlbäck B
    Rev Invest Clin; 1997 May; 49 Suppl 1():3-5. PubMed ID: 9291738
    [No Abstract]   [Full Text] [Related]  

  • 13. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families.
    Martinelli I; Mannucci PM; De Stefano V; Taioli E; Rossi V; Crosti F; Paciaroni K; Leone G; Faioni EM
    Blood; 1998 Oct; 92(7):2353-8. PubMed ID: 9746774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited resistance to activated protein C caused by presence of the FV:Q506 allele as a basis of venous thrombosis.
    Dahlbäck B; Zöller B; Hillarp A
    Haemostasis; 1996 Oct; 26 Suppl 4():301-14. PubMed ID: 8979136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation of Arg306 of factor V gene in Hong Kong Chinese.
    Chan WP; Lee CK; Kwong YL; Lam CK; Liang R
    Blood; 1998 Feb; 91(4):1135-9. PubMed ID: 9454741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited homozygous resistance to activated protein C.
    Villa P; Aznar J; Jorquera J; Mira Y; Vayá A; Fernández MA
    Thromb Haemost; 1995 Aug; 74(2):794-5. PubMed ID: 8585025
    [No Abstract]   [Full Text] [Related]  

  • 17. A Thai patient with the mutation of Arg306 of FV gene identical to the Hong Kong but not to the Cambridge type.
    Hiyoshi M; Hashimoto S; Tagawa S; Arnutti P; Prayoonwiwat W; Tatsumi N
    Thromb Haemost; 1999 Nov; 82(5):1553-4. PubMed ID: 10595653
    [No Abstract]   [Full Text] [Related]  

  • 18. High frequency of factor V Leiden mutation and prothrombin 20210A variant in Romanies of Eastern Hungary.
    Balogh I; Póka R; Losonczy G; Muszbek L
    Thromb Haemost; 1999 Nov; 82(5):1555-6. PubMed ID: 10595655
    [No Abstract]   [Full Text] [Related]  

  • 19. Discrimination between normal wildtype and carriers of coagulation factor V Leiden mutation by the activated protein C resistance test in the presence of factor V deficient plasma.
    Reuner KH; Litfin F; Patscheke H
    Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):41-5. PubMed ID: 9156566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APC-resistance as measured by a Textarin time assay: comparison to the APTT-based method.
    Hoagland LE; Triplett DA; Peng F; Barna L
    Thromb Res; 1996 Sep; 83(5):363-73. PubMed ID: 8873345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.